| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 34897 |
| 1 | PREDNISONE | 33909 |
| 2 | INFLIXIMAB | 26286 |
| 3 | METHOTREXATE SODIUM | 25248 |
| 4 | METHOTREXATE | 22763 |
| 5 | RITUXIMAB | 21285 |
| 6 | ACETAMINOPHEN | 20036 |
| 7 | ETANERCEPT | 18001 |
| 8 | ERGOCALCIFEROL | 14380 |
| 9 | ADALIMUMAB | 13501 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 9830 | 0.5791 |
| 1 | RITUXIMAB-ABBS | 1572 | 0.5228 |
| 2 | RITUXIMAB-PVVR | 708 | 0.4917 |
| 3 | IVOSIDENIB | 572 | 0.4712 |
| 4 | OMADACYCLINE | 202 | 0.4235 |
| 5 | DEFIBROTIDE SODIUM | 825 | 0.3266 |
| 6 | ISAVUCONAZONIUM SULFATE | 701 | 0.3238 |
| 7 | COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES | 365 | 0.3219 |
| 8 | PURIXAN | 197 | 0.3193 |
| 9 | PSEUDOEPHEDRINE HYDROCHLORIDE | 1628 | 0.3186 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 71946 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 53824 |
| 2 | RANK Ligand Inhibitor [EPC] | 34897 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 30432 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 25071 |
| 5 | Kinase Inhibitor [EPC] | 24676 |
| 6 | Atypical Antipsychotic [EPC] | 23400 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 22713 |
| 8 | Benzodiazepine [EPC] | 21799 |
| 9 | Proton Pump Inhibitor [EPC] | 15868 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthrax Protective Antigen-directed Antibody [EPC] | 1 | 0.5000 |
| 1 | Melanocortin 4 Receptor Agonist [EPC] | 14 | 0.3256 |
| 2 | Antileishmanial [EPC] | 79 | 0.3238 |
| 3 | Human Platelet-derived Growth Factor [EPC] | 674 | 0.3179 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 3795 | 0.3060 |
| 5 | Lead Chelator [EPC] | 21 | 0.3043 |
| 6 | Interferon gamma Blocker [EPC] | 18 | 0.2769 |
| 7 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 131 | 0.2646 |
| 8 | Adrenal Steroid Synthesis Inhibitor [EPC] | 138 | 0.2392 |
| 9 | RANK Ligand Inhibitor [EPC] | 34897 | 0.2046 |